FDA, Health Outcomes, Public Health and World Health

Psychedelic Inequities and Unexplored Risk: Colonization, Commercialization, and Regulation

Bill of Health

FEBRUARY 27, 2024

By excluding diverse contributions to the psychedelic field, we risk establishing psychedelic practices that exacerbate racial health inequities (disparities) in which people of color experience worse health outcomes as compared to whites on a population level.

Governance

Governance FDA World Health Health Outcomes

A Nutrition Label for Health IT

Health Populi

SEPTEMBER 8, 2021

The Pew Trusts recently discussed prospects for the FDA to regulate AI in health care. Building a nutrition label for health equity – learning from MITRE . Questions about the ethics and governance of AI in health are being posed globally.

FDA

FDA Governance Fraud World Health

Health Care Compliance Brief

Psychedelic Inequities and Unexplored Risk: Colonization, Commercialization, and Regulation

A Nutrition Label for Health IT

Stay Connected